Showing results (2451-2460 of 2,786) with videos related to
Sort By:
Pageof 279
Nature Microbiology|June 19, 2019
Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infectionVictor I Band, David A Hufnagel, Siddharth Jaggavarapu, et al.Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular CarcinomaMascha Mayer, Alexander Berger, Christian Leischner, et al.Cancer|February 15, 1996
Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterusS M Schwartz, N S Weiss, J R Daling, et al.ACS Central Science|December 4, 2020
In Situ Shape Control of Thermoplasmonic Gold Nanostars on Oxide Substrates for Hyperthermia-Mediated Cell DetachmentGail A Vinnacombe-Willson, Naihao Chiang, Leonardo Scarabelli, et al.Palliative & Supportive Care|August 22, 2023
Living with a blood cancer in later life: The complex challenges and related support needs of adults aged 75 and olderNaomi D Parker, Easton N Wollney, Carma L Bylund, et al.Psychosomatic Medicine|March 27, 2002
Critical incident exposure and sleep quality in police officersThomas C Neylan, Thomas J Metzler, Suzanne R Best, et al.JAMA|May 28, 1997
Characteristics of women with and without breast augmentationL S Cook, J R Daling, L F Voigt, et al.Nano Letters|April 15, 2017
Polymer-Pen Chemical Lift-Off LithographyXiaobin Xu, Qing Yang, Kevin M Cheung, et al.International Journal of Cancer|September 30, 1991
Incidence of histologic types of uterine sarcoma in relation to menstrual and reproductive historyS M Schwartz, N S Weiss, J R Daling, et al.Plos One|September 12, 2013
Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cellsSascha Venturelli, Alexander Berger, Alexander Böcker, et al.Pageof 279